vs
Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and UNIVERSAL TECHNICAL INSTITUTE INC (UTI). Click either name above to swap in a different company.
UNIVERSAL TECHNICAL INSTITUTE INC is the larger business by last-quarter revenue ($220.8M vs $207.8M, roughly 1.1× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 5.8%, a 51.6% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $-19.2M).
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.
IDYA vs UTI — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $207.8M | $220.8M |
| Net Profit | $119.2M | $12.8M |
| Gross Margin | — | — |
| Operating Margin | 52.2% | 7.1% |
| Net Margin | 57.4% | 5.8% |
| Revenue YoY | — | 9.6% |
| Net Profit YoY | 330.1% | -42.1% |
| EPS (diluted) | $1.33 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $220.8M | ||
| Q3 25 | $207.8M | $222.4M | ||
| Q2 25 | — | $204.3M | ||
| Q1 25 | — | $207.4M | ||
| Q4 24 | — | $201.4M | ||
| Q3 24 | $0 | $196.4M | ||
| Q2 24 | $0 | $177.5M | ||
| Q1 24 | $0 | $184.2M |
| Q4 25 | — | $12.8M | ||
| Q3 25 | $119.2M | $18.8M | ||
| Q2 25 | — | $10.7M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $22.2M | ||
| Q3 24 | $-51.8M | $18.8M | ||
| Q2 24 | $-52.8M | $5.0M | ||
| Q1 24 | $-39.6M | $7.8M |
| Q4 25 | — | 7.1% | ||
| Q3 25 | 52.2% | 11.2% | ||
| Q2 25 | — | 6.9% | ||
| Q1 25 | — | 8.1% | ||
| Q4 24 | — | 13.6% | ||
| Q3 24 | — | 13.3% | ||
| Q2 24 | — | 4.2% | ||
| Q1 24 | — | 6.1% |
| Q4 25 | — | 5.8% | ||
| Q3 25 | 57.4% | 8.4% | ||
| Q2 25 | — | 5.2% | ||
| Q1 25 | — | 5.5% | ||
| Q4 24 | — | 11.0% | ||
| Q3 24 | — | 9.6% | ||
| Q2 24 | — | 2.8% | ||
| Q1 24 | — | 4.2% |
| Q4 25 | — | $0.23 | ||
| Q3 25 | $1.33 | $0.33 | ||
| Q2 25 | — | $0.19 | ||
| Q1 25 | — | $0.21 | ||
| Q4 24 | — | $0.40 | ||
| Q3 24 | $-0.60 | $0.35 | ||
| Q2 24 | $-0.68 | $0.09 | ||
| Q1 24 | $-0.53 | $0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $786.9M | $162.8M |
| Total DebtLower is stronger | — | $101.4M |
| Stockholders' EquityBook value | $1.1B | $335.9M |
| Total Assets | $1.2B | $834.0M |
| Debt / EquityLower = less leverage | — | 0.30× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $162.8M | ||
| Q3 25 | $786.9M | $169.1M | ||
| Q2 25 | — | $70.7M | ||
| Q1 25 | — | $96.0M | ||
| Q4 24 | — | $172.0M | ||
| Q3 24 | $920.0M | $161.9M | ||
| Q2 24 | $701.7M | $115.5M | ||
| Q1 24 | $698.8M | $116.1M |
| Q4 25 | — | $101.4M | ||
| Q3 25 | — | $87.1M | ||
| Q2 25 | — | $73.8M | ||
| Q1 25 | — | $94.4M | ||
| Q4 24 | — | $120.1M | ||
| Q3 24 | — | $125.7M | ||
| Q2 24 | — | $137.3M | ||
| Q1 24 | — | $141.9M |
| Q4 25 | — | $335.9M | ||
| Q3 25 | $1.1B | $328.1M | ||
| Q2 25 | — | $306.8M | ||
| Q1 25 | — | $293.9M | ||
| Q4 24 | — | $280.0M | ||
| Q3 24 | $1.2B | $260.2M | ||
| Q2 24 | $931.7M | $239.4M | ||
| Q1 24 | $935.3M | $232.6M |
| Q4 25 | — | $834.0M | ||
| Q3 25 | $1.2B | $826.1M | ||
| Q2 25 | — | $740.8M | ||
| Q1 25 | — | $720.4M | ||
| Q4 24 | — | $753.8M | ||
| Q3 24 | $1.2B | $744.6M | ||
| Q2 24 | $973.7M | $706.0M | ||
| Q1 24 | $961.5M | $702.1M |
| Q4 25 | — | 0.30× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.24× | ||
| Q1 25 | — | 0.32× | ||
| Q4 24 | — | 0.43× | ||
| Q3 24 | — | 0.48× | ||
| Q2 24 | — | 0.57× | ||
| Q1 24 | — | 0.61× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $142.2M | $3.1M |
| Free Cash FlowOCF − Capex | $142.2M | $-19.2M |
| FCF MarginFCF / Revenue | 68.4% | -8.7% |
| Capex IntensityCapex / Revenue | 0.0% | 10.1% |
| Cash ConversionOCF / Net Profit | 1.19× | 0.24× |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | $16.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $3.1M | ||
| Q3 25 | $142.2M | $57.1M | ||
| Q2 25 | — | $18.1M | ||
| Q1 25 | — | $-789.0K | ||
| Q4 24 | — | $23.0M | ||
| Q3 24 | $-49.2M | $67.5M | ||
| Q2 24 | $-32.9M | $10.0M | ||
| Q1 24 | $-43.8M | $-2.5M |
| Q4 25 | — | $-19.2M | ||
| Q3 25 | $142.2M | $40.6M | ||
| Q2 25 | — | $6.8M | ||
| Q1 25 | — | $-11.7M | ||
| Q4 24 | — | $19.6M | ||
| Q3 24 | $-49.7M | $60.0M | ||
| Q2 24 | $-33.9M | $3.0M | ||
| Q1 24 | $-45.1M | $-8.4M |
| Q4 25 | — | -8.7% | ||
| Q3 25 | 68.4% | 18.3% | ||
| Q2 25 | — | 3.4% | ||
| Q1 25 | — | -5.7% | ||
| Q4 24 | — | 9.7% | ||
| Q3 24 | — | 30.6% | ||
| Q2 24 | — | 1.7% | ||
| Q1 24 | — | -4.6% |
| Q4 25 | — | 10.1% | ||
| Q3 25 | 0.0% | 7.4% | ||
| Q2 25 | — | 5.5% | ||
| Q1 25 | — | 5.3% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | — | 3.8% | ||
| Q2 24 | — | 4.0% | ||
| Q1 24 | — | 3.2% |
| Q4 25 | — | 0.24× | ||
| Q3 25 | 1.19× | 3.04× | ||
| Q2 25 | — | 1.69× | ||
| Q1 25 | — | -0.07× | ||
| Q4 24 | — | 1.04× | ||
| Q3 24 | — | 3.58× | ||
| Q2 24 | — | 2.01× | ||
| Q1 24 | — | -0.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IDYA
Segment breakdown not available.
UTI
| UTI | $142.8M | 65% |
| Concorde | $78.0M | 35% |
